Jefferies Maintains Buy On Entero Healthcare, Raises Target On Strong Growth Prospects

Sharad decodes why Jefferies remains bullish on Entero Healthcare. The brokerage has maintained its 'Buy' rating and raised its target price, citing strong execution, improving profitability and potential upside from future acquisitions. Jefferies believes better working-capital management could further support margin expansion and earnings growth, while inorganic opportunities may provide an additional boost to the company's growth trajectory. Investors will also watch how integration of acquisitions and operational efficiencies contribute to long-term value creation.